Professional Documents
Culture Documents
Endo-Thyroid Disorders in Children
Endo-Thyroid Disorders in Children
Endo-Thyroid Disorders in Children
! Thyroid hormone:
! potent regulator of metabolic rate.
! essential to the function of most organ systems.
Rosalind S. Brown. The thyroid in: Brook’s Clinical Pediatric Endocrionology. 2009: 255.
Placental iodine and thyroid
+
MOTHER PLACENTA FETUS
↑TBG
↑T4 Estrogens
↑T3
↑T4
↓TSH
hCG
Iodine I-
TRH TRH
metabolism
TBII TBII
TRH
TSH
T4 rT3
T4
T3 T2
T3
http://www.thyroidmanager.org/chapter/thyroid-hormones-in-brain-development-and-function/
+
Birth associated thyroid function
! Birth:
! Makes a transient and robust peak serum TSH & T4
" “neonatal surge”, followed by rapid changes in
the metabolism of thyroid hormone in peripheral
tissues.
! Normal neonatal thyroid surge typically lasts about
1 to 2 days.
Postnatal TSH, T4, T3, and rT3 secretion in the full-term and premature
infant in the first week of life.
+
Thyroid hormone synthesis
Follicle Colloid
TPO
T1 T2
Iodide (I-) NIS* I-
(20$40X)
Thyroglobulin
T4 T3 T4
TBG Thyroglobulin
T4 T3
T4
TBPA Thyroglobulin
T4 TSH
Alb
! fT4 (0.03%).
Only free hormone is
! fT3 (0.03%). active!
+
Peripheral thyroxine metabolism
I I I I I
O O O
I I I I I
OH OH OH
Tetraiodothyronine 3,5,3´ Triiodothyronine 3,3´,5´ Triiodothyronine
(T4, Thyroxine) (T3) (reverse T3)
+
Peripheral T4 metabolism
Hypothyroidism in children
+
Causes of hypothyroidism in pediatric
! Primary.
! CLT/Hashimotos thyroiditis.
! Congenital Abnormality.
! Iodine Deficiency.
! Drugs or Goitroges.
! Micellaneous.
! Secondary or Tertiary.
! Congenital abnormality.
! Acquired.
! Surgery.
! Radiation.
+
Hypothyroidism
! Onset:
! Congenital.
! Aquired.
+
Case ilustration
! ♀, 13
mo, referred by a pediatrician cause developmental
delay.
! Perinatalhistory: spontaneous delivery, term baby, BW:
3,200 g, BL: 50 cm, no asphyxia, no jaundice.
Age : 13 mo
BL : 65 cm
BW : 6.7 kg
! Primary Hypothyroidism.
! Permanent 1 : 3800 – 4000.
! Transient 1 : 50,000 (North America).
1 : 200 - 8000 (Europe).
o
!2 and/or 3o Hypothyroidism (1 : 50,000 –
100,000).
! Permanent.
! Transient.
! Dyshormonogenesis (10-15%).
! Clinical presentation.
! Goitrous: hypo, hyper, hyper-hypo, euthyroid.
! Primary myxedema.
! Lab study.
! TSH↑,#T4↓,#T3↓ :#overt#hypothyroidism.
! TSH↑,#T4#&T3#nl :#subclinical#/#compensated.
! TSH,#T4,#T3#nl :#euthyroid.
! TSH#↓,T4#&#T3#↑ :#hyperthyroidism.
! Anti TPO +, Anti Tg+.
+
Clinical symptoms of hypothyroidism
! Goiter.
! Poor growth velocity.
! Decrease appetite.
! Weakness.
! Cold intolerance.
! Constipation.
! Dry skin.
! ↑BMI.
! Delayed bone age.
+
Physical appearance of CLT
! Overt hypothyroidism:
! Increased doses gradually to avoid unwanted side effect "
full doses.
! Mild hypothyroidism:
! Full doses replacement.
! Compensated/subclinical:
! Treated with low doses (controversial).
! Euthyroid:
! Observed TFT every 6 mo.
+
Strategy of therapy
! Monitoring:
! Clinically.
! TFT: every 6-8 wks during adjusting doses or
every 6-12 mo after euthyroid state achieved.
! Growth velocity.
! Bone age.
+
Hyperthyroidism in children
Graves’"disease
+
Causes of hyperthyroidism in pediatric
! Primary.
! Graves’"disease.
! Plummer disease.
! TSH-induced hyperthyroidism.
! TSH-induced pituitary tumor.
! Central thyroid hormone resistance.
! Thyrotoxicosis without hyperthyroidism.
! CLT.
! Subacute thyroiditis.
! Thyroid hormone ingestion.
+
Graves’"disease
!Clinical presentation.
! Goiter (diffused).
!Lab study.
! TSH$↓,T4$&$T3$↑.
! Anti TPO +, Anti Tg+.
! TSI.
+
Therapy
Propanolol.
! Indication: in severe cases to control
cardiovascular overactivity.
! Dosage : 0.5-2.0 mg/kg/day given every 8
hours.
+
Medical therapy
Monitoring.
! Clinically.
! TFT.
! Every 4 to 6 weeks during adjusting doses " T4 and T3
normalizes.
! Every 4-6 mo once TFT normalized.
! Side effects.
! Erytematous rash, urticaria, arthralgias, granulocytopenia,
hepatitis, lupus like syndrome, thrombocytopenia.
+ Radioiodine ablation and surgical
thyroidectomy
! Should be consider:
! Failure to medical therapy or relaps.
! Lack of compliance.
+
CASE 1
! PDx:PTx? Pmx?
+
! K/L:'struma difusa(+)
! Th:'Simetris(+),'C/P'dbn
! Abd:'supel(+)
! Extr:'CRT<2detik
+
! Dd/?
! Pemeriksaan Dx yg diusulkan?
! Planning terapi?
! Planning monitoring?
+
CASE 3
! TD: 110/70
! TANNER A1M3P2
+
Laboratorium
! T4 3.05 μg/dL
! anti TPO and anti TG was positive with a titer of 481.83 and
1:10, respectively.
+
Dd/ struma
Source: Kehar M. Approach to goiter in children. 2012. [accessed March 7th 2017]. Available at:
https://www.researchgate.net/publication/274071419
+